Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lumora vs Risen Labs

Lumora
Graded #206

Higher grade

vs+8.899999999999991
Risen Labs
Graded #403

Lower grade

The verdict

Lumora takes it — 66.1/100 to 57.2/100.

Lumora grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lumora (Blue Skies MD LLC dba Lumora MD) is a physician-founded telehealth platform offering compounded semaglutide and tirzepatide in injectable and sublingual forms.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRisen Labs +9
36
45
Dose & formulationLumora +35
75
40
Clinical oversightLumora +8
87
79
Labs & monitoringLumora +12
76
64
FulfillmentLumora +6
74
68
Contract termsEven
55
55
Lumora · left barRisen Labs · right bar

The numbers

MetricLumoraRisen Labs
WeighScore66.1/10057.2/100
GradeCC
Scorecard rank#206#403
Semaglutide$199/mo (starting dose, plus a separate fee, compounded)Not disclosed
Tirzepatide$299/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Lumora

Graded #206 · C

Strengths

  • Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
  • Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
  • LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
  • Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
  • Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141

Where it loses points

  • Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
  • Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
  • Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
  • No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
  • Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list
Risen Labs

Graded #403 · C

Strengths

  • Names its compounding pharmacy (Olympia Pharmacy, a 503A compounding pharmacy) and legal entity (Risen Labs LLC)
  • Offers compounded semaglutide and tirzepatide as clinician-guided once-weekly injections
  • Focused clinical intake covering weight loss, men's health, and hormone protocols

Where it loses points

  • GLP-1 pricing is not published; it appears only after you complete the clinical intake
  • Available only to patients in New York and Colorado
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No LegitScript certification is displayed on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard